Fresenius Medical Care
FMS
167 hedge funds and large institutions have $598M invested in Fresenius Medical Care in 2024 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 64 increasing their positions, 45 reducing their positions, and 22 closing their positions.
97% more call options, than puts
Call options by funds: $1.62M | Put options by funds: $822K
42% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 45
0.64% less ownership
Funds ownership: 11.32% → 10.68% (-0.64%)
3% less funds holding
Funds holding: 172 → 167 (-5)
7% less capital invested
Capital invested by funds: $641M → $598M (-$42.7M)
18% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 22
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$2.42M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$1.17M |
| 3 |
BlackRock
New York
|
+$485K |
| 4 |
Corient Private Wealth
Miami,
Florida
|
+$472K |
| 5 |
CAM
Cresset Asset Management
Chicago,
Illinois
|
+$451K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$10.9M |
| 2 |
FMI
Fiduciary Management Inc
Milwaukee,
Wisconsin
|
-$4.86M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$4.28M |
| 4 |
GS
GTS Securities
New York
|
-$3.98M |
| 5 |
Millennium Management
New York
|
-$2.88M |
FMS Hedge Fund Activity: Q2 2024 in Review
167 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Fresenius Medical Care (FMS) for Q2 2024, worth a combined $598M — down 6.7% from $641M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of FMS and 18 opened new positions — a net loss of 4 holders — while 45 trimmed existing stakes and 64 added.
The largest buyer was Goldman Sachs, adding an estimated $2.42M. The largest seller was Pacer Advisors, exiting entirely with an estimated $10.9M sold.
- 167 institutional investors held Fresenius Medical Care (FMS) as of Q2 2024, down from 172 in Q1 2024.
- Funds reported $598M of Fresenius Medical Care stock for Q2 2024, down 6.7% quarter-over-quarter.
- 18 funds opened new Fresenius Medical Care positions in Q2 2024 and 22 closed out, a net change of -4 holders.
- The largest Fresenius Medical Care buyer in Q2 2024 was Goldman Sachs, an estimated $2.42M added.
- The largest Fresenius Medical Care seller in Q2 2024 was Pacer Advisors, an estimated $10.9M sold.
Based on aggregated 13F filings for Q2 2024.